{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:21Z","timestamp":1791328881084,"version":"4.3.1"},"reference-count":72,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,10,1]]},"DOI":"10.1210\/mend.11.11.0006","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:29:39Z","timestamp":1389202179000},"page":"1593-1607","source":"Crossref","is-referenced-by-count":236,"title":["Biphasic Regulation of Breast Cancer Cell Growth by Progesterone: Role of the Cyclin-Dependent Kinase Inhibitors, p21 and p27Kip1"],"prefix":"10.1210","volume":"11","author":[{"given":"Steve D.","family":"Groshong","sequence":"first","affiliation":[{"name":"The Molecular Biology Program (S.D.G., B.G., T.A.L., R.A.S., K.B.H.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth I.","family":"Owen","sequence":"additional","affiliation":[{"name":"University of Colorado Health Sciences Center, Departments of Medicine and Pathology (G.I.O., C.A.L., K.B.H.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryn","family":"Grimison","sequence":"additional","affiliation":[{"name":"The Molecular Biology Program (S.D.G., B.G., T.A.L., R.A.S., K.B.H.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene E.","family":"Schauer","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biophysics and Genetics (I.E.S., R.A.S.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Todd","sequence":"additional","affiliation":[{"name":"Department of Pharmacology (M.C.T., T.A.L.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Langan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology (M.C.T., T.A.L.), Denver, Colorado 80262"},{"name":"The Molecular Biology Program (S.D.G., B.G., T.A.L., R.A.S., K.B.H.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Sclafani","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biophysics and Genetics (I.E.S., R.A.S.), Denver, Colorado 80262"},{"name":"The Molecular Biology Program (S.D.G., B.G., T.A.L., R.A.S., K.B.H.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Lange","sequence":"additional","affiliation":[{"name":"University of Colorado Health Sciences Center, Departments of Medicine and Pathology (G.I.O., C.A.L., K.B.H.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn B.","family":"Horwitz","sequence":"additional","affiliation":[{"name":"University of Colorado Health Sciences Center, Departments of Medicine and Pathology (G.I.O., C.A.L., K.B.H.), Denver, Colorado 80262"},{"name":"The Molecular Biology Program (S.D.G., B.G., T.A.L., R.A.S., K.B.H.), Denver, Colorado 80262"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041200374224000_R1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/edrv-11-2-266","article-title":"Progestin regulation of cellular proliferation.","volume":"11","author":"Clarke","year":"1990","journal-title":"Endocr Rev"},{"key":"2019041200374224000_R2","first-page":"146","article-title":"The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?","volume":"13","author":"Horwitz","year":"1992","journal-title":"Endocr Rev"},{"key":"2019041200374224000_R3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.168640","article-title":"Predicting response to endocrine therapy in human breast cancer: a hypothesis.","volume":"189","author":"Horwitz","year":"1975","journal-title":"Science"},{"key":"2019041200374224000_R4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM198312013092240","article-title":"Progesterone receptors as a prognostic factor in stage II breast cancer.","volume":"309","author":"Clark","year":"1983","journal-title":"N Engl J Med"},{"key":"2019041200374224000_R5","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","article-title":"Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.","volume":"9","author":"Lydon","year":"1995","journal-title":"Genes Dev"},{"key":"2019041200374224000_R6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0092-8674(95)90034-9","article-title":"Cyclin D1 provides a link between development and oncogenesis in the retina and breast.","volume":"82","author":"Sicinski","year":"1995","journal-title":"Cell"},{"key":"2019041200374224000_R7","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/MCB.13.6.3577","article-title":"Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.","volume":"13","author":"Musgrove","year":"1993","journal-title":"Mol Cell Biol"},{"key":"2019041200374224000_R8","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1073\/pnas.91.17.8022","article-title":"Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.","volume":"91","author":"Musgrove","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200374224000_R9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/369669a0","article-title":"Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.","volume":"369","author":"Wang","year":"1994","journal-title":"Nature"},{"key":"2019041200374224000_R10","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","article-title":"The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.","volume":"332","author":"Colditz","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041200374224000_R11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(91)90241-O","article-title":"Evaluating the benefits and risks of postmenopausal hormone therapy.","volume":"91","author":"Cummings","year":"1991","journal-title":"Am J Med"},{"key":"2019041200374224000_R12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.1995.03530020055032","article-title":"Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.","volume":"274","author":"Stanford","year":"1995","journal-title":"JAMA"},{"key":"2019041200374224000_R13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0046-8177(89)80003-6","article-title":"Oral contraceptive use influences resting breast proliferation.","volume":"20","author":"Anderson","year":"1989","journal-title":"Hum Pathol"},{"key":"2019041200374224000_R14","first-page":"193","article-title":"Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.","volume":"130","author":"Going","year":"1988","journal-title":"Am J Pathol"},{"key":"2019041200374224000_R15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bjc.1988.185","article-title":"The effect of age and menstrual cycle upon proliferative activity of normal human breast.","volume":"58","author":"Potten","year":"1988","journal-title":"Br J Cancer"},{"key":"2019041200374224000_R16","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1126\/science.7863327","article-title":"Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.","volume":"267","author":"Halevy","year":"1995","journal-title":"Science"},{"key":"2019041200374224000_R17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1126\/science.2683075","article-title":"G1 events and regulation of cell proliferation.","volume":"246","author":"Pardee","year":"1989","journal-title":"Science"},{"key":"2019041200374224000_R18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7863329","article-title":"p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.","volume":"267","author":"Parker","year":"1994","journal-title":"Science"},{"key":"2019041200374224000_R19","first-page":"3389","article-title":"Induction of p21 (WAF-1\/CIP1) during differentiation.","volume":"9","author":"Steinman","year":"1994","journal-title":"Oncogene"},{"key":"2019041200374224000_R20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases.","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"key":"2019041200374224000_R21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.7863328","article-title":"Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.","volume":"267","author":"Skapek","year":"1995","journal-title":"Science"},{"key":"2019041200374224000_R22","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(17)38062-6","article-title":"Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor.","volume":"253","author":"Horwitz","year":"1978","journal-title":"J Biol Chem"},{"key":"2019041200374224000_R23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/edrv-16-5-559","article-title":"Growth factors in breast cancer.","volume":"16","author":"Dickson","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041200374224000_R24","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/MCB.11.10.5032","article-title":"Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor a, epidermal growth factor receptor, c-fos, and c-myc genes.","volume":"11","author":"Musgrove","year":"1991","journal-title":"Mol Cell Biol"},{"key":"2019041200374224000_R25","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1210\/endo-113-6-2195","article-title":"In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation.","volume":"113","author":"Horwitz","year":"1983","journal-title":"Endocrinology"},{"key":"2019041200374224000_R26","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.1016\/S0021-9258(19)50100-4","article-title":"A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms.","volume":"267","author":"Meyer","year":"1992","journal-title":"J Biol Chem"},{"key":"2019041200374224000_R27","first-page":"1347","article-title":"A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform.","volume":"8","author":"Sartorius","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2019041200374224000_R28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/333185a0","article-title":"The N-terminal region of the chicken progesterone receptor specifies target gene activation.","volume":"333","author":"Tora","year":"1988","journal-title":"Nature"},{"key":"2019041200374224000_R29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/endo-111-1-30","article-title":"Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens.","volume":"111","author":"Boyd-Leinen","year":"1982","journal-title":"Endocrinology"},{"key":"2019041200374224000_R30","first-page":"5063","article-title":"Characterisation of progesterone receptor A and B expression in human breast cancer.","volume":"55","author":"Graham","year":"1995","journal-title":"Cancer Res"},{"key":"2019041200374224000_R31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0960-0760(93)90072-5","article-title":"The ontogeny of gene expression of progestin receptors in the female rat brain.","volume":"47","author":"Kato","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041200374224000_R32","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1210\/endo-107-4-1234","article-title":"Circannual rhythms in steroid receptor concentration and nuclear binding in the chick oviduct.","volume":"107","author":"Spelsberg","year":"1980","journal-title":"Endocrinology"},{"key":"2019041200374224000_R33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0092-8674(82)90218-5","article-title":"Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.","volume":"28","author":"Horwitz","year":"1982","journal-title":"Cell"},{"key":"2019041200374224000_R34","first-page":"3868","article-title":"New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.","volume":"54","author":"Sartorius","year":"1994","journal-title":"Cancer Res"},{"key":"2019041200374224000_R35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0092-8674(94)90541-X","article-title":"Rules to replicate by.","volume":"79","author":"Heichman","year":"1994","journal-title":"Cell"},{"key":"2019041200374224000_R36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","article-title":"Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age.","volume":"79","author":"Hunter","year":"1994","journal-title":"Cell"},{"key":"2019041200374224000_R37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0092-8674(94)90542-8","article-title":"Mitosis in transition.","volume":"79","author":"King","year":"1994","journal-title":"Cell"},{"key":"2019041200374224000_R38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0092-8674(94)90539-8","article-title":"Ordering S phase and M phase in the cell cycle.","volume":"79","author":"Nurse","year":"1994","journal-title":"Cell"},{"key":"2019041200374224000_R39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","article-title":"G1 phase progression: cycling on cue.","volume":"79","author":"Sherr","year":"1994","journal-title":"Cell"},{"key":"2019041200374224000_R40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control.","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"2019041200374224000_R41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0092-8674(94)90186-4","article-title":"Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.","volume":"79","author":"Peter","year":"1994","journal-title":"Cell"},{"key":"2019041200374224000_R42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0022-4731(86)90323-7","article-title":"Progesterone metabolism in T47Dco human breast cancer cells. II. Intracellular metabolic pathway of progesterone and synthetic progestins.","volume":"25","author":"Horwitz","year":"1986","journal-title":"J Steroid Biochem"},{"key":"2019041200374224000_R43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0092-8674(95)90201-5","article-title":"Steroid hormone receptors: many actors in search of a plot.","volume":"83","author":"Beato","year":"1995","journal-title":"Cell"},{"key":"2019041200374224000_R44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","article-title":"Inhibitors of mammalian G1 cyclin-dependent kinases.","volume":"9","author":"Sherr","year":"1995","journal-title":"Genes Dev"},{"key":"2019041200374224000_R45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell cycle control causing specific inhibition of cyclin D\/cdk4.","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"2019041200374224000_R46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1101\/gad.8.1.9","article-title":"p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.","volume":"8","author":"Polyak","year":"1994","journal-title":"Genes Dev"},{"key":"2019041200374224000_R47","first-page":"1139","article-title":"Lack of nuclear RB protein staining in G0\/middle G1 cells: correlation to changes in total RB protein level.","volume":"6","author":"Xu","year":"1991","journal-title":"Oncogene"},{"key":"2019041200374224000_R48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00666179","article-title":"EGF receptor expression, regulation, and function in breast cancer.","volume":"29","author":"Chrysogelos","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2019041200374224000_R49","first-page":"4204","article-title":"Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression.","volume":"50","author":"Dotzlaw","year":"1990","journal-title":"Cancer Res"},{"key":"2019041200374224000_R50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00666180","article-title":"The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.","volume":"29","author":"Fox","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"2019041200374224000_R51","first-page":"2051","article-title":"Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.","volume":"51","author":"Murphy","year":"1991","journal-title":"Cancer Res"},{"key":"2019041200374224000_R52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0006-291X(88)90504-9","article-title":"Progestin regulation of EGF receptor mRNA accumulation in T47D human breast cancer cells.","volume":"150","author":"Murphy","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041200374224000_R53","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(94)90257-7","article-title":"Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.","volume":"79","author":"Kato","year":"1994","journal-title":"Cell"},{"key":"2019041200374224000_R54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0039-128X(84)80029-X","article-title":"The role of progestins and progesterone receptors in the treatment of breast cancer.","volume":"44","author":"Sedlacek","year":"1984","journal-title":"Steroids"},{"key":"2019041200374224000_R55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0092-8674(95)90401-8","article-title":"Specificity of receptor tyrosine kinase signaling: transient vs. sustained extracellular signal-regulated kinase activation.","volume":"80","author":"Marshall","year":"1995","journal-title":"Cell"},{"key":"2019041200374224000_R56","first-page":"31","article-title":"Regulation of p21waf\/cip1 expression through mitogen-activated protein kinase signaling pathway.","volume":"56","author":"Liu","year":"1996","journal-title":"Cancer Res"},{"key":"2019041200374224000_R57","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1101\/gad.8.15.1750","article-title":"p21-containing cyclin kinases exist in both active and inactive states.","volume":"8","author":"Zhang","year":"1994","journal-title":"Genes Dev"},{"key":"2019041200374224000_R58","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.14.3.2066","article-title":"D-Type cyclin-dependent protein kinase activity in mammalian cells.","volume":"14","author":"Matsushine","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2019041200374224000_R59","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1101\/gad.11.7.847","article-title":"New functional activities for the p21 family of CDK inhibitors.","volume":"11","author":"LaBaer","year":"1997","journal-title":"Genes Dev"},{"key":"2019041200374224000_R60","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1073\/pnas.90.13.5889","article-title":"Signal transduction via the MAP kinases: proceed at your own RSK.","volume":"90","author":"Blenis","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200374224000_R61","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1126\/science.272.5269.1797","article-title":"Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor.","volume":"272","author":"Galcheva-Gargova","year":"1996","journal-title":"Science"},{"key":"2019041200374224000_R62","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1073\/pnas.89.4.1330","article-title":"p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.","volume":"89","author":"Qian","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200374224000_R63","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0960-9822(00)00155-X","article-title":"PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation.","volume":"4","author":"Dikic","year":"1994","journal-title":"Curr Biol"},{"key":"2019041200374224000_R64","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0960-9822(00)00154-8","article-title":"EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor.","volume":"4","author":"Traverse","year":"1994","journal-title":"Curr Biol"},{"key":"2019041200374224000_R65","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/MCB.14.7.4427","article-title":"Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent.","volume":"14","author":"Yamauchi","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2019041200374224000_R66","first-page":"5071","article-title":"Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.","volume":"48","author":"Sarup","year":"1988","journal-title":"Cancer Res"},{"key":"2019041200374224000_R67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jcp.1041550110","article-title":"Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland.","volume":"155","author":"Haslam","year":"1993","journal-title":"J Cell Physiol"},{"key":"2019041200374224000_R68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0960-0760(91)90188-B","article-title":"Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells.","volume":"40","author":"Krusekopf","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041200374224000_R69","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jcb.240450211","article-title":"Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line.","volume":"45","author":"Modiano","year":"1991","journal-title":"J Cell Biochem"},{"key":"2019041200374224000_R70","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1083\/jcb.66.1.188","article-title":"Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining.","volume":"66","author":"Krishan","year":"1975","journal-title":"J Cell Biol"},{"key":"2019041200374224000_R71","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/bi00393a045","article-title":"Immunologic analysis of human breast cancer progesterone receptors. I. Immunoaffinity purification of transformed receptors and monoclonal antibody production.","volume":"26","author":"Estes","year":"1987","journal-title":"Biochemistry"},{"key":"2019041200374224000_R72","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4.","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/11\/11\/1593\/10735308\/mend1593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:20:25Z","timestamp":1647908425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/11\/11\/1593\/2756751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10,1]]},"references-count":72,"aliases":["10.1210\/me.11.11.1593"],"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/mend.11.11.0006","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10,1]]}}}